Abbott | ABT - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Agilent USD 2.27B 35M 2026-03
AtriCure USD 73.19M 8.33M 2026-03
Baxter International USD 3.69B 723M 2026-03
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Bio-Rad Laboratories USD 917M 400M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
Cooper Companies USD 1.6B 482.9M 2025-12
Danaher USD 7.46B 653M 2026-03
Dexcom USD 2.22B 81.3M 2026-03
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Globus Medical USD 482.46M 16.04M 2026-03
Insulet USD 687.5M 7.4M 2026-03
Integra LifeSciences USD 346.85M 109.14M 2026-03
Intuitive Surgical USD 2.51B 3.2M 2026-03
J&J USD 57.72B 3.59B 2026-03
Masimo USD 325.4M 46.2M 2026-03
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 216.87M 22.89M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Smith & Nephew USD 1.54B 236M 2025-12
Solventum Corp USD 3.35B 210M 2026-03
Stryker USD 6.32B 1.48B 2026-03
Tandem Diabetes Care USD 247.96M 5.24M 2026-03
Teleflex USD 728.05M 33.98M 2026-03
Terumo JPY 540.73B 1.03B 2026-03
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Zimmer Biomet Holdings USD 2.86B 280.6M 2026-03